Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Ketamine for Acute Pain Crisis in SCD
NCT04330183Phase 4Completed
- Sponsor
- Rhode Island Hospital
- Start
- Jul 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in sickle cell disease (SCD), sponsored by Rhode Island Hospital. Started Jul 2020; status: completed.
02
Drugs
ketamine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT04330183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04330183.